VC-backed Bolt Biotherapeutics debuts IPO

Bolt Biotherapeutics Inc has gone public after pricing its 11.5 million shares at $20 per share.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this